医美概念股(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BK1593 医美概念股

未开盘 12-22 16:00:00

1,150.989

-6.033

-0.52%

最高1,165.911	最低1,144.470	成交量3,433万
今开1,163.316	昨收1,157.021	日振幅1.85%
总市值0.00	流通市值0.00	总股本0.00
成交额5.06亿	换手率--	流通股本0.00
市净率1.707607	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"医美概念股","latestPrice":1150.9885,"timestamp":1766390888436,"preClose":1157.0212,"halted":0,"volume":34328741,"delay":0,"changeRate":-0.005214,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":-6.032715,"latestTime":"12-22 16:00:00","open":1163.316,"high":1165.9114,"low":1144.4697,"amount":505730747,"amplitude":0.018532,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766453400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1766367000000,1766376000000],[1766379600000,1766390400000]],"pbRate":1.707607,"peRate":24.678455,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK1593","defaultTab":"news","newsList":[{"id":"2593483841","title":"昊海生物科技(06826)12月22日斥资43.49万港元回购1.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2593483841","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593483841?lang=zh_cn&edition=full","pubTime":"2025-12-22 17:11","pubTimestamp":1766394668,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，该公司于2025年12月22日斥资43.49万港元回购1.7万股股份，每股回购价格为25.54-25.6港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384423.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","BK1161","06826"],"gpt_icon":0},{"id":"2593436686","title":"每日卖空追踪 | 昊海生物科技 12月22日卖空量成交7000股，卖空比例为7.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593436686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593436686?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:30","pubTimestamp":1766392237,"startTime":"0","endTime":"0","summary":"昊海生物科技北京时间12月22日，跌0.62%，卖空量成交7000股，较上一交易日增加250%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163721a46998a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163721a46998a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06826","BK1593"],"gpt_icon":0},{"id":"2593691434","title":"瑞丽医美盘中异动 股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593691434","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593691434?lang=zh_cn&edition=full","pubTime":"2025-12-22 13:57","pubTimestamp":1766383038,"startTime":"0","endTime":"0","summary":"2025年12月22日下午盘13时57分，瑞丽医美股票出现异动，股价急速下挫5.33%。截至发稿，该股报0.160港元/股，成交量10万股，换手率0.02%，振幅7.69%。瑞丽医美股票所在的医疗及医学美容服务行业中，整体涨幅为0.01%。其相关个股中，脑动极光-B、佰泽医疗、美中嘉和涨幅较大，振幅较大的相关个股有中国生物科技服务、脑动极光-B、明基医院，振幅分别为19.57%、16.30%、13.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222135718a6c0023f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222135718a6c0023f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1209","02135"],"gpt_icon":0},{"id":"2593431043","title":"复锐医疗科技盘中异动 下午盘大幅拉升5.03%报4.590港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593431043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593431043?lang=zh_cn&edition=full","pubTime":"2025-12-22 13:00","pubTimestamp":1766379627,"startTime":"0","endTime":"0","summary":"2025年12月22日下午盘13时00分，复锐医疗科技股票出现波动，股价大幅拉升5.03%。截至发稿，该股报4.590港元/股，成交量75.72万股，换手率0.16%，振幅7.55%。资金方面，该股资金流入129.714万港元，流出197.445万港元。复锐医疗科技股票所在的医疗设备及用品行业中，整体跌幅为0.15%。其相关个股中，复锐医疗科技、君百延集团、先瑞达医疗-B涨幅较大，振幅较大的相关个股有华检医疗、巨星医疗控股、复锐医疗科技，振幅分别为19.71%、11.46%、7.32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222130027953b7e8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222130027953b7e8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01696","BK1585","BK1593","BK1100"],"gpt_icon":0},{"id":"2593125369","title":"复星高管回应！为何巨额收购“971”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2593125369","media":"药械VIP","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593125369?lang=zh_cn&edition=full","pubTime":"2025-12-21 10:23","pubTimestamp":1766283783,"startTime":"0","endTime":"0","summary":"12月15日，复星医药公告，拟出资约14.12亿元，收购绿谷（上海）医药科技有限公司51%的股权。2024年，971在中国卖出200多万盒。但各界对971的质疑从未间断。2025年，因绿谷医药未完成上市后确证性临床研究，国家药监局没有重新批准971的上市申请，该药停产。12月15日晚间，复星医药高管在电话会上表示：根据现有临床证据，他们看好971的疗效与前景。接下来，复星医药将推动971的上市后确证性临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251221111029a4652ebd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251221111029a4652ebd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02196","BK1515","BK1593"],"gpt_icon":0},{"id":"2593121986","title":"医药生物行业周报：推荐CXO+科研服务板块的估值切换机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2593121986","media":"开源证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593121986?lang=zh_cn&edition=full","pubTime":"2025-12-21 00:00","pubTimestamp":1766246400,"startTime":"0","endTime":"0","summary":"全球融资环境整体已处于回暖阶段，CRO 需求端已出现明确拐点，继续推荐2026 年创新药产业链整体性的机会。随着需求端持续改善，我们预计头部CXO+科研服务公司业绩有望持续改善，当前位置看2026 年估值性价比明显，首推相关标的估值切换的机会。医药布局思路及推荐标的整体上，我们持续看好创新药及其产业链，创新药方向重点推荐小核酸赛道的机会，并重点推荐头部CXO+科研服务估值切换的机会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251221173627a6bd0916&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251221173627a6bd0916&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06127","BK1593","01530","HK0000165453.HKD","02269","BK1583"],"gpt_icon":0},{"id":"2592011781","title":"昊海生物科技于12月19日斥资28.88万港元回购1.13万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2592011781","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592011781?lang=zh_cn&edition=full","pubTime":"2025-12-20 14:45","pubTimestamp":1766213100,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　昊海生物科技（06826）发布公告，该公司于2025年12月19日斥资28.88万港元回购1.13万股股份，每股回购价格为25.54-25.56港元。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-12-20/doc-inhcmsti6669056.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1593","06826","BK1161"],"gpt_icon":0},{"id":"2592163490","title":"云南瑞丽“圆愿小屋”：用爱守护童年 用心陪伴成长","url":"https://stock-news.laohu8.com/highlight/detail?id=2592163490","media":"新华网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592163490?lang=zh_cn&edition=full","pubTime":"2025-12-19 18:37","pubTimestamp":1766140620,"startTime":"0","endTime":"0","summary":"在云南省德宏傣族景颇族自治州瑞丽市，有一个名为“圆愿小屋”的服务点，15年来持续守护着一群特殊孩子的成长。站在新的发展节点，瑞丽市正着力总结“圆愿小屋”的经验做法，实现复制推广。未来，“圆愿小屋”将继续秉持“小屋大爱”理念，持续深耕边疆特殊儿童关爱事业，努力成为全省乃至全国受艾滋病影响儿童关爱服务的示范样板，让特殊儿童在阳光下茁壮成长、逐梦远航。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-12-19/doc-inhciuac5636476.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1209","02135","BK1593"],"gpt_icon":0},{"id":"2592117971","title":"三生制药张昊：多数创新药企出海仍依赖代理商，海外市场布局紧迫性提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2592117971","media":"钛媒体快报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592117971?lang=zh_cn&edition=full","pubTime":"2025-12-19 17:48","pubTimestamp":1766137688,"startTime":"0","endTime":"0","summary":"钛媒体App 12月19日消息，钛媒体集团 2025 T-EDGE  12月8日-12月21日全球同步开启。会上，三生制药国际事业部负责人张昊表示，虽然中国创新药已经有了长足的进步，但放眼全球市场所占比重不高，仅有少数企业能在海外直接营销，多数企业仍依赖代理商开展业务，这更凸显了布局海外市场的紧迫性。所以，不管\"借船出海\"还是\"造船出海”，最终的目的都是渗透、占领海外市场，海外是中国创新药必须探索和抢占的巨大蓝海。（2025 T-EDGE）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219175045a6b699a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219175045a6b699a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01530","BK1583","BK1161","06978","BK1593","HK0000165453.HKD","BK1574"],"gpt_icon":0},{"id":"2592577131","title":"复星医药：控股子公司药品获美国FDA临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2592577131","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592577131?lang=zh_cn&edition=full","pubTime":"2025-12-19 17:20","pubTimestamp":1766136033,"startTime":"0","endTime":"0","summary":"南方财经12月19日电，复星医药(600196.SH)公告称，控股子公司上海复宏汉霖生物技术股份有限公司及其控股子公司获美国FDA批准开展HLX18（重组抗PD-1人源化单克隆抗体注射液）用于治疗多种实体瘤的I期临床试验。复宏汉霖拟于条件具备后于美国开展该药品的I期临床试验。HLX18是复星医药自主研发的纳武利尤单抗生物类似药，拟用于多种癌症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512193596838564.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","BK0175","BK0012","BK1515","BK0188","BK0239","600196","BK0060","BK0028","BK1593","02196","BK0196","BK0183","BK0096","BK0187"],"gpt_icon":0},{"id":"2592999481","title":"复星医药双线突围：14亿押注争议药物，全球合作对冲研发风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2592999481","media":"投资时报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592999481?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:52","pubTimestamp":1766134346,"startTime":"0","endTime":"0","summary":"评估报告显示，截至2025年9月30日，绿谷医药股东全部权益的评估值为16.74亿元。为了应对挑战，复星医药正持续加大向创新药的转型力度。就在市场将焦点投向绿谷医药的同时，复星医药的全球布局仍在提速。12月18日，复星医药宣布其控股子公司复星医药产业与美国Clavis Bio公司签订《合作及选择权协议》，双方将共同选定靶点推进临床前药物开发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219165312a45f4c19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219165312a45f4c19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1515","BK1191","02196"],"gpt_icon":0},{"id":"2592656195","title":"每日卖空追踪 | 昊海生物科技 12月19日卖空量成交200股，卖空比例为0.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592656195","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592656195?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:30","pubTimestamp":1766133036,"startTime":"0","endTime":"0","summary":"昊海生物科技北京时间12月19日，涨0.55%，卖空量成交200股，较上一交易日减少97.22%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163631a6b6478c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163631a6b6478c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","06826","BK1161"],"gpt_icon":0},{"id":"2592619994","title":"每日卖空追踪 | 复星医药 12月19日卖空量成交14.25万股，卖空比例为3.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592619994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592619994?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:30","pubTimestamp":1766133027,"startTime":"0","endTime":"0","summary":"复星医药北京时间12月19日，涨2.23%，卖空量成交14.25万股，较上一交易日增加22.84%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163425a45f3590&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163425a45f3590&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1191","02196","BK1515"],"gpt_icon":0},{"id":"2592726154","title":"每日卖空追踪 | 三生制药 12月19日卖空量成交306.7万股，卖空比例为12.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592726154","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592726154?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:30","pubTimestamp":1766133022,"startTime":"0","endTime":"0","summary":"三生制药北京时间12月19日，涨2.99%，卖空量成交306.7万股，较上一交易日增加134.03%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163307a6b64388&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163307a6b64388&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01530","BK1583","BK1161","HK0000165453.HKD","BK1593"],"gpt_icon":0},{"id":"2592196452","title":"每日卖空追踪 | 四环医药 12月19日卖空量成交147.2万股，卖空比例为4.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592196452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592196452?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:30","pubTimestamp":1766133013,"startTime":"0","endTime":"0","summary":"四环医药北京时间12月19日，涨2.44%，卖空量成交147.2万股，较上一交易日减少47.58%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163106a45f314a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163106a45f314a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00460","BK1593","BK1600","BK1191","BK1515"],"gpt_icon":0},{"id":"2592196484","title":"四环医药12月19日获主力加仓653.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592196484","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592196484?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:15","pubTimestamp":1766132155,"startTime":"0","endTime":"0","summary":"12月19日, 四环医药股价涨2.44%，报收1.26元，成交金额4085.5万元，换手率0.35%，振幅6.50%，量比1.47。四环医药今日主力资金净流入653.3万元，连续3日净流入，上一交易日主力净流入770.2万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为37.50%，平均涨幅为5.01%。该股近5个交易日下跌3.82%，主力资金累计净流入1071.7万元；近20日主力资金累计净流入2133.6万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219162157a45f25ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219162157a45f25ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00460","BK1600","BK1191","BK1593","BK1515"],"gpt_icon":0},{"id":"2592819915","title":"复星医药12月19日主力净流入272.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2592819915","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592819915?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:15","pubTimestamp":1766132145,"startTime":"0","endTime":"0","summary":"12月19日, 复星医药股价涨2.23%，报收21.08元，成交金额9571.9万元，换手率0.84%，振幅3.30%，量比0.68。复星医药今日主力资金净流入272.3万元，上一交易日主力净流出7.3万元。该股近5个交易日下跌5.33%，主力资金累计净流出2684.4万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入312.9万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219161951a45f22d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219161951a45f22d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","BK1191","BK1515","BK1593"],"gpt_icon":0},{"id":"2592632119","title":"复锐医疗科技12月19日主力净流入161.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2592632119","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592632119?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:15","pubTimestamp":1766132141,"startTime":"0","endTime":"0","summary":"12月19日, 复锐医疗科技股价涨12.92%，报收4.37元，成交金额1100.2万元，换手率0.56%，振幅14.21%，量比3.93。复锐医疗科技今日主力资金净流入161.9万元，上一交易日主力净流出0万元。该股近5个交易日上涨9.25%，主力资金累计净流入201.8万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入216.6万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219161910a45f21fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219161910a45f21fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1593","BK1585","01696"],"gpt_icon":0},{"id":"2592542401","title":"三生制药盘中异动 大幅拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592542401","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592542401?lang=zh_cn&edition=full","pubTime":"2025-12-19 10:02","pubTimestamp":1766109755,"startTime":"0","endTime":"0","summary":"2025年12月19日早盘10时02分，三生制药股票出现异动，股价快速上涨5.04%。截至发稿，该股报26.680港元/股，成交量533.479万股，换手率0.21%，振幅5.67%。三生制药股票所在的药品行业中，整体涨幅为0.34%。其相关个股中，三生制药、凯莱英、君圣泰医药-B涨幅较大，振幅较大的相关个股有三生制药、康臣药业、君圣泰医药-B，振幅分别为5.51%、4.37%、4.21%。三生制药公司简介：投资控股,及本集团主要在中国从事开发、生产、营销及销售生物医药产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219100235a6b4e12f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219100235a6b4e12f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","HK0000165453.HKD","BK1593","01530"],"gpt_icon":0},{"id":"2592513686","title":"【券商聚焦】交银国际：临近年末 续看好新BD交易集中落地机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2592513686","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592513686?lang=zh_cn&edition=full","pubTime":"2025-12-19 09:20","pubTimestamp":1766107245,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报，本周多项超10亿美元的BD交易相继落地，合作伙伴既有MNC也有中小型生物科技公司。临近年末，该机构继续看好新BD交易集中落地机会。展望2026 年，该机构认为板块稳中向好态势延续，但影响市场表现的核心因素或呈分化态势，后续选股逻辑或将重回基本面和估值，即关注存在基本面预期差、当前仍被低估的个股。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/YzM1MzBiNWM5MmUxNDYxMGFiODk0MWI5MWJmNTU3YjMxMTA4MTkwNzI1ODY3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YzM1MzBiNWM5MmUxNDYxMGFiODk0MWI5MWJmNTU3YjMxMTA4MTkwNzI1ODY3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971853","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","LU0348783233.USD","LU0417516902.SGD","LU1770034418.SGD","LU2328871848.SGD","LU2488822045.USD","BK1588","SG9999014674.SGD","LU0417516738.SGD","LU2476274720.SGD","IE00B543WZ88.USD","01099","BK1197","HK0000165453.HKD","BK1583","LU0588546209.SGD","BK1147","BK1191","LU0561508036.HKD","LU0348735423.USD","LU1303224171.USD","06160","03329","LU1115378108.SGD","01789","LU0634319403.HKD","02367","LU0307460666.USD","LU1720050803.USD","BK1617","LU0348784397.USD","LU0348825331.USD","09926","LU0348766576.USD","LU2778985437.USD","02268","LU0417516571.SGD","LU1794554557.SGD","BK1500","IE00B5MMRT66.SGD","LU2476274308.USD","BK1593","LU0540923850.HKD","LU1251922891.USD","LU2399975544.HKD","BK1585","02196","02228","03933","09688"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0231},{"period":"3month","weight":-0.0137},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3084},{"period":"ytd","weight":0.2862}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"name":"BK1593","nameEN":"BK1593"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医美概念股(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医美概念股(BK1593)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医美概念股,BK1593,医美概念股股票,医美概念股股票老虎,医美概念股股票老虎国际,医美概念股行情,医美概念股股票行情,医美概念股股价,医美概念股股市,医美概念股股票价格,医美概念股股票交易,医美概念股股票购买,医美概念股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医美概念股(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医美概念股(BK1593)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}